|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
10
|
|
pubmed:dateCreated |
2000-10-30
|
|
pubmed:abstractText |
Despite their well-known side-effects, corticosteroids (Cs) are currently used after kidney transplantation. Avoidance of Cs may improve patient quality of life and eventual long-term survival. We report on a regimen using antithymocyte globulin (ATG) and mycophenolate mofetil (MMF) for induction, and cyclosporin (CsA) plus MMF for maintenance treatment of recipients of primary kidney transplantation.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
0931-0509
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
15
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1673-6
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:11007839-Acute Disease,
pubmed-meshheading:11007839-Adrenal Cortex Hormones,
pubmed-meshheading:11007839-Adult,
pubmed-meshheading:11007839-Antilymphocyte Serum,
pubmed-meshheading:11007839-Biopsy,
pubmed-meshheading:11007839-Cyclosporine,
pubmed-meshheading:11007839-Cytomegalovirus Infections,
pubmed-meshheading:11007839-Drug Administration Schedule,
pubmed-meshheading:11007839-Drug Therapy, Combination,
pubmed-meshheading:11007839-Graft Rejection,
pubmed-meshheading:11007839-Humans,
pubmed-meshheading:11007839-Immunosuppressive Agents,
pubmed-meshheading:11007839-Incidence,
pubmed-meshheading:11007839-Kidney,
pubmed-meshheading:11007839-Kidney Transplantation,
pubmed-meshheading:11007839-Middle Aged,
pubmed-meshheading:11007839-Mycophenolic Acid,
pubmed-meshheading:11007839-Pilot Projects,
pubmed-meshheading:11007839-Postoperative Complications
|
|
pubmed:year |
2000
|
|
pubmed:articleTitle |
Prevention of acute rejection with antithymocyte globulin, avoiding corticosteroids, and delaying cyclosporin after renal transplantation.
|
|
pubmed:affiliation |
Department of Nephrology and Clinical Immunology, Institut de Transplantation et de Recherche en Transplantation (ITERT), Nantes, France.
|
|
pubmed:publicationType |
Journal Article
|
